Cardiometabolic syndrome and chronic kidney disease.
Chronic kidney disease (CKD) is increasingly recognized as a major risk factor for end-stage renal disease (ESRD), cardiovascular (CV) disease, and CV-related premature death. More than 8 million people in the United States have CKD; therefore, preventive stratiegies should be directed at identifying risk factors for this condition. There is growing evidence implicating the cardiometabolic syndrome, a clustering of CV risk factors that include obesity, insulin resistance, compensatory hyperinsulinemia, dysglycemia, atherogenic dyslipidemia, and hypertension. Factors mediating this relationship include increased glomerular filtration, increased vascular permeability, oxidative and endoplasmic reticulum stress, activation of the renin-angiotensin system, and inappropriate secretion of growth factors. The consequences are microalbuminuria, a marker of inflammation and endothelial dysfunction, renal vascular proliferation, extracellular matrix expansion, and CKD. Prevention of CKD should be directed at controlling all components of the cardiometabolic syndrome, with the ultimate goal of reducing the burden imposed by ESRD.
Lastra
Guido
G
Manrique
Camila
C
McFarlane
Samy I
SI
Sowers
James R
JR
D000419:Albuminuria / Q000150:complications; D002908:Chronic Disease; D004721:Endoplasmic Reticulum / Q000502:physiology; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D007333:Insulin Resistance / Q000502:physiology; D007674:Kidney Diseases / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology*; D018384:Oxidative Stress / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology; D012307:Risk Factors